Mixed Dyslipidemias Completed Phase 4 Trials for Pravastatin (DB00175)

Back to Mixed Dyslipidemias

Also known as: Mixed Hyperlipidaemia / Mixed Dyslipidemia / Mixed Hyperlipidemia / Mixed hypercholesterolemia / Broad- or floating-betalipoproteinemia / Type V hyperlipidaemia / Type V hyperlipidemia / Type V lipidaemia / Type V lipidemia / Hyperlipoproteinemia Type V / Type V hyperlipoproteinemia / Fredrickson Type V lipidemia / Fredrickson Type V lipidaemia / Type V hyperlipoproteinaemia

IndicationStatusPhase
DBCOND0073163 (Mixed Dyslipidemias)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01256476Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaTreatment